Stauffer syndrome, clinical implications and knowledge gaps, does size matter? Case report

[1]  N. Sharma,et al.  Stauffer Syndrome: A Comprehensive Review of the Icteric Variant of the Syndrome , 2019, Cureus.

[2]  Manal M. Hassan,et al.  IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion. , 2019, The Journal of clinical investigation.

[3]  P. Panwar,et al.  Paraneoplastic hepatic dysfunction with jaundice in a case of primary renal synovial sarcoma: A very rare scenario , 2019, Urology case reports.

[4]  F. D. da Silva,et al.  Stauffer's syndrome: A comprehensive review and proposed updated diagnostic criteria. , 2018, Urologic oncology.

[5]  P. Thorson,et al.  Reversible intrahepatic cholestasis in metastatic prostate cancer: An uncommon paraneoplastic syndrome. , 2018, Molecular and clinical oncology.

[6]  D. McCarthy,et al.  Hepatic Dysfunction in Renal Cell Carcinoma: Not What You Think? , 2017, Digestive Diseases and Sciences.

[7]  E. Gonzalez-Ballina,et al.  Stauffer's Syndrome Variant as an Unusual Case of Painless Jaundice. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  A. B. Fernández,et al.  Prothrombin complex concentrate (Octaplex®) for postsurgical bleeding control in a Stauffer’s syndrome , 2012, Annals of Hematology.

[9]  J. C. Ayala,et al.  Síndrome de Stauffer con ictericia, una manifestación paraneoplásica del carcinoma renal: a propósito de un caso , 2010 .

[10]  Carlos A Garcia,et al.  Stauffer's syndrome with jaundice, a paraneoplastic manifestation of renal cell carcinoma: a case report. , 2010, Archivos espanoles de urologia.

[11]  J. Papadakis,et al.  Unusual causes of intrahepatic cholestatic liver disease. , 2007, World journal of gastroenterology.

[12]  S. Alazemi,et al.  Stauffer’s syndrome variant with cholestatic jaundice , 2006, Journal of General Internal Medicine.

[13]  D. Trafalis,et al.  Stauffer's syndrome variant associated with renal cell carcinoma , 2005, International journal of urology : official journal of the Japanese Urological Association.

[14]  N. Grigoriadis,et al.  Cholestatic jaundice as a paraneoplastic manifestation of prostate adenocarcinoma. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[15]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[16]  J. Blay,et al.  Role of interleukin‐6 in the paraneoplastic inflammatory syndrome associated with renal‐cell carcinoma , 1997, International journal of cancer.

[17]  S. Hadziyannis,et al.  Cholestatic jaundice as a paraneoplastic manifestation of renal cell carcinoma. , 1997, European journal of gastroenterology & hepatology.

[18]  J. Thompson,et al.  Paraneoplastic manifestations of renal cell carcinoma. , 1996, Seminars in urologic oncology.

[19]  S. Chang,et al.  Inhibitory effects of suramin on a human renal cell carcinoma line, causing nephrogenic hepatic dysfunction. , 1992, The Journal of urology.

[20]  D. Skinner,et al.  Non-metastatic hepatic dysfunction associated with renal carcinoma. , 1978, The Journal of urology.